Quanterix Co. (NASDAQ:QTRX) Holdings Raised by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. lifted its holdings in Quanterix Co. (NASDAQ:QTRX) by 129.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 192,444 shares of the company’s stock after purchasing an additional 108,503 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in Quanterix were worth $2,494,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Allspring Global Investments Holdings LLC increased its position in Quanterix by 22.3% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 12,844 shares of the company’s stock worth $303,000 after purchasing an additional 2,340 shares during the last quarter. Easterly Investment Partners LLC lifted its holdings in shares of Quanterix by 551.1% during the first quarter. Easterly Investment Partners LLC now owns 78,734 shares of the company’s stock valued at $1,855,000 after acquiring an additional 66,642 shares during the period. Williams Jones Wealth Management LLC. bought a new position in shares of Quanterix in the first quarter valued at about $1,327,000. State Board of Administration of Florida Retirement System raised its holdings in shares of Quanterix by 42.1% in the first quarter. State Board of Administration of Florida Retirement System now owns 14,341 shares of the company’s stock valued at $338,000 after buying an additional 4,250 shares during the last quarter. Finally, Lord Abbett & CO. LLC raised its holdings in Quanterix by 22.9% during the 1st quarter. Lord Abbett & CO. LLC now owns 1,757,153 shares of the company’s stock worth $41,398,000 after purchasing an additional 326,876 shares during the last quarter. Institutional investors own 86.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on QTRX shares. The Goldman Sachs Group decreased their target price on Quanterix from $35.00 to $24.00 and set a “buy” rating for the company in a research report on Tuesday, July 9th. Scotiabank reduced their price target on Quanterix from $32.00 to $28.00 and set a “sector outperform” rating for the company in a research report on Monday, August 12th. Finally, TD Cowen dropped their price objective on Quanterix from $17.00 to $15.00 and set a “hold” rating on the stock in a research note on Friday, August 9th.

Quanterix Stock Up 3.1 %

NASDAQ:QTRX opened at $13.85 on Tuesday. The firm has a market capitalization of $531.56 million, a PE ratio of -13.19 and a beta of 1.36. Quanterix Co. has a twelve month low of $10.50 and a twelve month high of $29.70. The stock’s 50-day simple moving average is $12.72 and its 200 day simple moving average is $14.06.

Quanterix (NASDAQ:QTRX) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02). Quanterix had a negative return on equity of 11.52% and a negative net margin of 30.71%. The company had revenue of $34.38 million for the quarter, compared to the consensus estimate of $34.19 million. During the same quarter last year, the business earned ($0.16) earnings per share. On average, analysts anticipate that Quanterix Co. will post -0.88 EPS for the current fiscal year.

Insider Activity

In related news, Director David R. Walt purchased 47,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The stock was acquired at an average price of $13.29 per share, for a total transaction of $624,630.00. Following the completion of the acquisition, the director now owns 1,487,342 shares of the company’s stock, valued at $19,766,775.18. This represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 6.90% of the company’s stock.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.